Siemens Atellica IM Anti-Thyroglobulin II (aTgII) - HSA Registration DE0506382
Access comprehensive regulatory information for Siemens Atellica IM Anti-Thyroglobulin II (aTgII) in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0506382 and owned by Siemens Healthcare Diagnostics Products Limited. The device was registered on November 16, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Atellica® IM Anti-Thyroglobulin II (aTgII) assay is for in vitro diagnostic use in the quantitative measurement of autoantibodies against thyroglobulin in human serum and plasma (dipotassium EDTA, lithium heparin, sodium heparin) using the Atellica® Analyzer. Anti-thyroglobulin (aTg, TgAb) measurements are used as an aid in the diagnosis of Hashimoto’s and Graves’ diseases, which are autoimmune diseases affecting the thyroid gland.